Combination therapy with biologic agents in rheumatic diseases: current and future prospects.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2016, v. 8, n. 5, p. 192, doi. 10.1177/1759720X16665330
- By:
- Publication type:
- Article
Works matching IS 1759720X AND DT 2016 AND VI 8 AND IP 5
Results: 4
1
2
Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2016, v. 8, n. 5, p. 172, doi. 10.1177/1759720X16664324
- By:
- Publication type:
- Article
3
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2016, v. 8, n. 5, p. 180, doi. 10.1177/1759720X16664306
- By:
- Publication type:
- Article
4
Best performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2016, v. 8, n. 5, p. 165, doi. 10.1177/1759720X16658032
- By:
- Publication type:
- Article